AI Technologies for Enhanced and Celerated High-Field WB-MRI
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
Single-center, cross-sectional observational study assessing the feasibility of advanced accelerated MRI sequences versus standard ones in terms of image quality, diagnostic reliability, and acquisition time.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Consecutive adults (≥18 y.o.) admitted to the UO for W MRI for screening procedure.
Consecutive adult male patients (≥18 y.o.) admitted to the UO for WB-MRI for screening procedure and focus on prostate.
Disqualifiers
refused to consent
claustrophobia
metal prosthesis potentially affecting image quality
Trial population
Consecutive adults (≥18 years) admitted to the Advanced Imaging for Personalized Medicine Unit for screening WB-MRI, including a male subgroup undergoing prostate-focused imaging to rule out malignancy. Subjects refusing consent, with claustrophobia, or with metallic implants compromising image quality are excluded.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Image quality
Comparison between standard and accelerated MRI sequences in terms of diagnostic accuracy, acquisition time.
Time frame
30 monthsSecondary outcomes
1
Image quality - subjective
Likert-scale evaluation of images between independent readers with different levvels of experience
Time frame
30-36 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: